Centre for Inflammatory Disease Department of Immunology and Inflammation Imperial College London Hammersmith Hospital London UK

Department of Internal Medicine 4 Medical University Innsbruck Innsbruck Austria

Department of Medicine Division of Nephrology The Ohio State University Wexner Medical Center Columbus Ohio USA

Department of Medicine Johns Hopkins University Baltimore Maryland USA

Department of Nephrology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Nephrology Royal Preston Hospital Lancashire Teaching Hospitals NHS Foundation Trust Preston UK

Division of Kidney Diseases and Hypertension Department of Medicine Donald and Barbara Zucker School of Medicine at Hofstra Northwell Great Neck New York

Division of Nephrology and Rheumatology Department of Medicine Johns Hopkins University Baltimore Maryland USA

Division of Nephrology Department of Medicine Johns Hopkins University Baltimore Maryland USA

Division of Nephrology Department of Medicine University of North Carolina at Chapel Hill North Carolina USA

Division of Rheumatology Department of Medicine Johns Hopkins University Baltimore Maryland USA

Ludwig Maximilians Universität München Munich Germany

Renal Urology and Transplantation Unit Manchester University Hospitals Manchester UK

Trinity Health Kidney Centre Trinity Translational Medicine Institute Trinity College Dublin Ireland

Washington University School of Medicine St Louis Missouri USA

Zobrazit více v PubMed

Stone J.H., Merkel P.A., Spiera R., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221–232. PubMed PMC

Jones R.B., Cohen Tervaert J.W., Hauser T., et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363:211–220. PubMed

Walsh M., Merkel P.A., Peh C., et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020;382:622–631. PubMed PMC

Wallace Z.S., Yun H., Curtis J.R., et al. ANCA-associated vasculitis management in the United States: data from the rheumatology informatics system for effectiveness (RISE) registry. J Rheumatol. 2021;48:1060–1064. PubMed

Abdulakeem A., Adams T., Ahmad S., et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637–1645. PubMed PMC

Horby P., Lim W.S., Emberson J.R., et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384:693–704. PubMed PMC

Lee L.Y., Cazier J., Angelis V., et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395:1919–1926. PubMed PMC

Williamson E.J., Walker A.J., Bhaskaran K., et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. PubMed PMC

Waldman M., Soler M.J., García-Carro C., et al. Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. Kidney Int. 2021;99:227–237. PubMed PMC

Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions